8 Mar 2019


PDF 2.4 MB

Shandong Xinhua is in an leading position in the manufacturing technology and capacity for antipyretics and analgesics in China, also for the drugs of central nervous system, steroids, cardio cerebrovascular system and anti- infection agents. The total capacity of API is more than 35,000mt per year,and  products Analgin, Ibuprofen, Acetylsalicylic Acid, Caffeine and Levodopa are on the top position in the worldwide. Shandong Xinhua is also the key manufacturer for finished dosage formulation in China with the capacity of 10 billion tablets, 1 billion injection units and 200 million capsules per year. 

Content provided by our supplier

Shandong Xinhua Pharmaceutical (USA) Inc.

  • US
  • 2018
    On CPHI since

Other Content from Shandong Xinhua Pharmaceutical (USA) Inc. ()